Benjamin Mercilena, Singh Jay, Pandey Avanish Kumar, Thukral Neha, Kumari Sarita, Palanichamy Jayanth Kumar, Bakhshi Sameer, Pushpam Deepam, Kumar Akash, Gupta Aditya Kumar, Meena Jagdish Prasad, Singh Amitabh, Tanwar Pranay, Singh Amar Ranjan, Bhalla Sherry, Chopra Anita
Laboratory Oncology, AIIMS, New Delhi, India.
Department of Biochemistry, AIIMS, New Delhi, India.
Lab Invest. 2025 May 29;105(9):104201. doi: 10.1016/j.labinv.2025.104201.
Whole-transcriptomic sequencing (WTS) has remarkably advanced our understanding of B-lineage acute lymphoblastic leukemia (B-ALL), allowing for detailed gene expression profiling and discovery of novel therapeutically relevant subtypes. The aim of this study was to evaluate the diagnostic and prognostic relevance of combining WTS with traditional genetic methods in risk-stratifying B-ALL. In a cohort of 394 patients (301 children and 93 adults), conventional techniques such as fluorescence in situ hybridization, cytogenetics, and reverse-transcription PCR identified sentinel chromosomal abnormalities like BCR::ABL1, TCF3::PBX1, ETV6::RUNX1, and KMT2A-R (rearranged), and ploidy status. WTS was performed on selected 257 patients to identify subtypes such as Ph-like, DUX4-R, PAX5-altered (PAX5-ALT), MEF2D-R, BCL2-R, UBTF-R, PAX5 P80R, NUTM1-R, ZNF384-R, ZNF384-like, ETV6::RUNX1-like, IKZF1 N159Y, and HLF-R. We used a multipronged strategy to identify the borderline subtypes such as Ph-like, PAX5-ALT, and CRLF2 (non-Ph-like), by integrating gene expression signatures using t-distributed stochastic neighbor embedding, subtype-defining mutations, gene fusions, and copy number assessments. Our integrated approach not only identifies prognostically relevant sentinel molecular subtypes but also increases subtype assignment in upto ∼95% of B-ALL patients. The pro-B immunophenotype was found to be more frequent in UBTF-R and MEF2D-R ALL. Ph-like ALL was associated with poor remission rates and higher minimal residual disease positivity, while DUX4-R showed favorable prognosis. We further categorized pediatric patients into 3 risk groups: favorable (hyperdiploid, ETV6::RUNX1, and DUX4-R), poor (BCR::ABL1, Ph-like, KMT2A-R, TCF3::PBX1, iAMP21, and hypodiploid), and intermediate (PAX5-ALT, PAX5 P80R, NUTM1-R, MEF2D-R, CRLF2 [non-Ph-like], UBTF-R, ZNF384-R, ZNF384-like, BCL2-R, IKZF1 N159Y, ETV6::RUNX1-like, and B-rest). Event-free survival and overall survival were significantly associated with this risk stratification. In adults, Ph-like ALL showed worse prognosis, particularly, in BCR::ABL1-negative ALL patients. Among the DUX4-R B-ALL, those with IKZF1 deletion had worse event-free survival and overall survival. We also identified several novel gene rearrangements in different subtypes of B-ALL. Our study demonstrated that integrating WTS with traditional methods provides a comprehensive, accurate, and cost-effective strategy for risk assessment and treatment planning for B-ALL.
全转录组测序(WTS)显著推进了我们对B系急性淋巴细胞白血病(B-ALL)的理解,使得详细的基因表达谱分析以及发现新的具有治疗相关性的亚型成为可能。本研究的目的是评估在B-ALL风险分层中,将WTS与传统遗传方法相结合的诊断和预后相关性。在一个包含394例患者(301名儿童和93名成人)的队列中,荧光原位杂交、细胞遗传学和逆转录PCR等传统技术鉴定出了如BCR::ABL1、TCF3::PBX1、ETV6::RUNX1和KMT2A-R(重排)等标志性染色体异常以及倍性状态。对选定的257例患者进行了WTS,以鉴定如Ph样、DUX4-R、PAX5改变(PAX5-ALT)、MEF2D-R、BCL2-R、UBTF-R、PAX5 P80R、NUTM1-R、ZNF384-R、ZNF384样、ETV6::RUNX1样、IKZF1 N159Y和HLF-R等亚型。我们采用多管齐下的策略,通过使用t分布随机邻域嵌入整合基因表达特征、亚型定义突变、基因融合和拷贝数评估,来鉴定如Ph样、PAX5-ALT和CRLF2(非Ph样)等临界亚型。我们的综合方法不仅识别出了与预后相关的标志性分子亚型,还将高达约95%的B-ALL患者的亚型分类增加。在UBTF-R和MEF2D-R ALL中,前B免疫表型更为常见。Ph样ALL与缓解率低和微小残留病阳性率高相关,而DUX4-R显示出良好的预后。我们进一步将儿科患者分为3个风险组:良好(超二倍体、ETV6::RUNX1和DUX4-R)、不良(BCR::ABL1、Ph样、KMT2A-R、TCF3::PBX1、iAMP21和亚二倍体)和中间(PAX5-ALT、PAX5 P80R、NUTM1-R、MEF2D-R、CRLF2 [非Ph样]、UBTF-R、ZNF384-R、ZNF384样、BCL2-R、IKZF1 N159Y、ETV6::RUNX1样和B-rest)。无事件生存期和总生存期与这种风险分层显著相关。在成人中,Ph样ALL预后较差,尤其是在BCR::ABL1阴性的ALL患者中。在DUX4-R B-ALL中,那些存在IKZF1缺失的患者无事件生存期和总生存期较差。我们还在B-ALL的不同亚型中鉴定出了几种新的基因重排。我们的研究表明,将WTS与传统方法相结合为B-ALL的风险评估和治疗规划提供了一种全面、准确且具有成本效益的策略。